# Can ARA-290 provide neuroprotection against oxidative stress in aging cells?

Canonical source: https://retacompare.com/research/can-ara-290-provide-neuroprotection-against-oxidative-stress-in-aging-cells

Peptide Longevity Q&A · 2016-08-13


    ARA-290, an EPO-derived peptide, has demonstrated neuroprotective effects in research models by reducing neuronal death due to oxidative stress. It activates ERK1/2 and Akt pathways, suggesting potential benefits for neuroprotection in aging-related neurological conditions.

 What the research shows

The study investigated the neuroprotective effects of a novel erythropoietin (EPO)-derived peptide, referred to as MK-X, in PC12 cells under conditions of oxidative stress. The researchers aimed to evaluate the peptide's ability to mitigate neuronal death caused by reactive oxygen species. The results indicated that MK-X effectively reduced neuronal death, similar to the effects observed with EPO. Additionally, MK-X was shown to induce long-lasting activation of the extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) and Akt pathways. The study also noted that the neuroprotective effects of MK-X were abolished upon treatment with inhibitors targeting ERK1/2 and Akt, highlighting the significance of these pathways in mediating MK-X's effects. Unlike EPO, MK-X did not promote cellular proliferation.

 Why it matters for longevity

The findings of this research have implications for understanding neuroprotection in the context of aging. As individuals age, the risk of neurodegenerative diseases increases, often exacerbated by oxidative stress. By demonstrating that ARA-290 can protect neurons from oxidative damage, the peptide may offer a potential therapeutic avenue for mitigating age-related neurological decline. The activation of critical signaling pathways such as ERK1/2 and Akt further suggests that ARA-290 could play a role in enhancing cellular resilience against stressors commonly encountered in aging populations. This research aligns with broader efforts to explore how peptides can influence healthspan and longevity by targeting underlying mechanisms of cellular aging and neuroprotection.

 Key findings at a glance

ARA-290 (MK-X) mimics EPO's neuroprotective effects in PC12 cells.

It reduces neuronal death caused by oxidative stress.

MK-X activates ERK1/2 and Akt signaling pathways.

The neuroprotective effects are inhibited by specific pathway inhibitors.

Unlike EPO, MK-X does not induce cellular proliferation.

 How ARA-290 works (background)

ARA-290, derived from erythropoietin, is designed to engage with the EPO receptor in a manner that mimics its neuroprotective properties without promoting erythropoiesis (red blood cell production). The peptide's mechanism involves the activation of intracellular signaling pathways, particularly ERK1/2 and Akt, which are crucial for cell survival and response to stress. By enhancing these pathways, ARA-290 may help neurons withstand oxidative stress, a common contributor to neurodegeneration and cognitive decline associated with aging. This mechanism positions ARA-290 as a candidate for further exploration in the context of neuroprotection and longevity.

 Safety, caveats, and what we don't yet know

While the research presents promising findings regarding ARA-290's neuroprotective effects, it is important to note that the study was conducted in vitro using PC12 cells, which may not fully replicate the complexity of human neurological systems. Further research is necessary to evaluate the peptide's efficacy and safety in vivo, particularly in aging populations and individuals with neurodegenerative diseases. Additionally, the long-term effects and potential side effects of ARA-290 remain to be clarified, as well as its interactions with other treatments for neuroprotection.

 Bottom line

ARA-290 has shown potential neuroprotective effects against oxidative stress in research models, suggesting a possible role in supporting neuronal health in aging. Further studies are needed to explore its application in clinical settings.

 Related questions

 What are the potential benefits of ARA-290 for cognitive health?

Research indicates that ARA-290 may help protect neurons from oxidative stress, which is a significant factor in cognitive decline associated with aging. Its effects on critical signaling pathways could enhance neuronal resilience.

 How does oxidative stress affect aging and neurodegeneration?

Oxidative stress contributes to cellular damage and is linked to neurodegenerative diseases. It can lead to neuronal death, cognitive decline, and other age-related conditions, making its mitigation crucial for healthy aging.

 What other peptides are being studied for neuroprotection?

Several peptides, including those derived from EPO and other neurotrophic factors, are under investigation for their potential neuroprotective properties. These studies aim to identify effective treatments for neurodegenerative diseases and cognitive decline.

 Source: PubMed · CNS Neurol Disord Drug Targets · published 2016-08-13.

## Sources

- PubMed · CNS Neurol Disord Drug Targets: https://pubmed.ncbi.nlm.nih.gov/27528469/